96 related articles for article (PubMed ID: 25388155)
41. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
44. Expressions and effects of G250, Bax and Bcl-2 in rats with renal clear cell carcinoma.
Wang YQ; Liu C; Shan ZF; Liu QZ; Cui YS; Yang LQ
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4488-4492. PubMed ID: 30058688
[TBL] [Abstract][Full Text] [Related]
45. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
46. The survivin:fas ratio in pediatric renal tumors.
Takamizawa S; Scott D; Wen J; Grundy P; Bishop W; Kimura K; Sandler A
J Pediatr Surg; 2001 Jan; 36(1):37-42. PubMed ID: 11150435
[TBL] [Abstract][Full Text] [Related]
47. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma.
Puzianowska-Kuznicka M; Nauman A; Madej A; Tanski Z; Cheng S; Nauman J
Cancer Lett; 2000 Jul; 155(2):145-52. PubMed ID: 10822129
[TBL] [Abstract][Full Text] [Related]
48. XIAP expression is an independent prognostic marker in clear-cell renal carcinomas.
Ramp U; Krieg T; Caliskan E; Mahotka C; Ebert T; Willers R; Gabbert HE; Gerharz CD
Hum Pathol; 2004 Aug; 35(8):1022-8. PubMed ID: 15297970
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
Ma C; Lu B; Sun E
Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
[TBL] [Abstract][Full Text] [Related]
50. Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma.
Kamiya Y; Puzianowska-Kuznicka M; McPhie P; Nauman J; Cheng SY; Nauman A
Carcinogenesis; 2002 Jan; 23(1):25-33. PubMed ID: 11756220
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma.
Zeng FC; Zeng MQ; Huang L; Li YL; Gao BM; Chen JJ; Xue RZ; Tang ZY
Onco Targets Ther; 2016; 9():2131-41. PubMed ID: 27110129
[TBL] [Abstract][Full Text] [Related]
52. Regulation of endothelial cell survival and death by the MAP kinase/ERK kinase kinase 3 - glyceraldehyde-3-phosphate dehydrogenase signaling axis.
Li YQ; Ngo A; Hoffmann P; Ferrante A; Hii CS
Cell Signal; 2019 Jun; 58():20-33. PubMed ID: 30831195
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors.
Miller MA; Karacay B; Breslow NE; Li S; O'Dorisio MS; Grundy PE; Sandler AD
J Pediatr Hematol Oncol; 2005 Jan; 27(1):11-4. PubMed ID: 15654272
[TBL] [Abstract][Full Text] [Related]
54. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.
Cullere X; Plovie E; Bennett PM; MacRae CA; Mayadas TN
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14284-9. PubMed ID: 26540726
[TBL] [Abstract][Full Text] [Related]
55. Netrin-1: The new tumor markers in renal clear cell carcinoma.
Gong BS; Feng Q
Asian Pac J Trop Med; 2015 Jun; 8(6):489-93. PubMed ID: 26194836
[TBL] [Abstract][Full Text] [Related]
56. [The pathology and DNA quantitative study of renal clear cell carcinoma in children].
Luo B; Gui L; Pang Y; Wu W; Ding A
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):188-90. PubMed ID: 11866975
[TBL] [Abstract][Full Text] [Related]
57. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
Xiong C; Liu H; Chen Z; Yu Y; Liang C
Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.
Tang W; Shi Z; Zhu Y; Shan Z; Jiang A; Wang A; Chen M; Bao Y; Ju G; Xu W; Wang J
Sci Rep; 2023 Jul; 13(1):11668. PubMed ID: 37468683
[TBL] [Abstract][Full Text] [Related]
59. [Expression of survivin in nasal and paranasal sinus carcinoma].
Zhang YP; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Nov; 41(11):843-7. PubMed ID: 17283539
[TBL] [Abstract][Full Text] [Related]
60. Structural Insights into the Molecular Recognition between Cerebral Cavernous Malformation 2 and Mitogen-Activated Protein Kinase Kinase Kinase 3.
Wang X; Hou Y; Deng K; Zhang Y; Wang DC; Ding J
Structure; 2015 Jun; 23(6):1087-96. PubMed ID: 25982527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
